1
|
Tadiparthi K, Venkatesh S. Synthetic approaches toward butenolide‐containing natural products. J Heterocycl Chem 2022. [DOI: 10.1002/jhet.4480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
| | - Swathy Venkatesh
- Department of Chemistry CHRIST (Deemed to be University) Hosur Road Bangalore
| |
Collapse
|
2
|
Bao X, Zeng L, Jin J, Cui S. Facile Synthesis of γ-Butenolides and Maleic Anhydrides via Annulation of α-Keto Acids and Triazenyl Alkynes. J Org Chem 2022; 87:2821-2830. [DOI: 10.1021/acs.joc.1c02727] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Xiaodong Bao
- Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
| | - Linwei Zeng
- Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
| | - Jian Jin
- CAS Key Laboratory of Synthetic Chemistry of Natural Substances, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China
| | - Sunliang Cui
- Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
| |
Collapse
|
3
|
Yang M, Chen C, Yi X, Li Y, Wu X, Li Q, Ban S. Thiosquaramide-catalysed asymmetric double Michael addition of 2-(3H)-furanones to nitroolefines. Org Biomol Chem 2019; 17:2883-2886. [DOI: 10.1039/c9ob00330d] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
2,2,4-Trisubstituted butenolides bearing a quaternary stereogenic center were smoothly constructed with excellent stereoselectivities under mild conditions.
Collapse
Affiliation(s)
- Mengchen Yang
- School of Pharmacy
- Shanxi Medical University
- Taiyuan
- China
| | - Chen Chen
- School of Pharmacy
- Shanxi Medical University
- Taiyuan
- China
| | - Xing Yi
- School of Pharmacy
- Shanxi Medical University
- Taiyuan
- China
| | - Yuan Li
- School of Pharmacy
- Shanxi Medical University
- Taiyuan
- China
| | - Xiaoqin Wu
- Scientific Instrument Center
- Shanxi University
- Taiyuan
- China
| | - Qingshan Li
- School of Pharmacy
- Shanxi Medical University
- Taiyuan
- China
- Shanxi Key laboratory of Chronic Inflammatory Targeted Drugs
| | - Shurong Ban
- School of Pharmacy
- Shanxi Medical University
- Taiyuan
- China
- Shanxi Key laboratory of Chronic Inflammatory Targeted Drugs
| |
Collapse
|
4
|
Mal K, Das I. α-Keto Thioesters as Building Blocks for Accessing γ-Hydroxybutenolides and Oxazoles. Adv Synth Catal 2017. [DOI: 10.1002/adsc.201700329] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- Kanchan Mal
- Organic and Medicinal Chemistry Division; CSIR-Indian Institute of Chemical Biology; 4, Raja S. C. Mullick Road Jadavpur, Kolkata 700032 India
| | - Indrajit Das
- Organic and Medicinal Chemistry Division; CSIR-Indian Institute of Chemical Biology; 4, Raja S. C. Mullick Road Jadavpur, Kolkata 700032 India
| |
Collapse
|
5
|
Talbi A, Arfaoui A, Bsaibess T, Lotfi Efrit M, Gaucher A, Prim D, M Rabet H. Selective synthesis of mono- and bis-butenolide α-aminomethyl adducts. Org Biomol Chem 2017; 15:3298-3303. [PMID: 28358156 DOI: 10.1039/c7ob00206h] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The selective installation of α-methylamine residues at the butenolide core is described using α-bromomethylene-γ-butenolide and primary as well as secondary amines in methanol at 0 °C. The preparation of mono- and bis-butenolide α-adducts is described. Bis-γ-butenolide adducts as well as mono α-aminomethyl-γ-butenolides can be selectively obtained depending on the nature of the reacting primary amine. In contrast, the use of secondary amines allows two different pathways leading either to the expected amino derivatives or to the formation of a C-O bond.
Collapse
Affiliation(s)
- Arbia Talbi
- Université de Tunis El Manar, Faculté des Sciences de Tunis, Laboratoire de Synthèse Organique Sélective et Hétérocyclique-Evaluation de l'Activité Biologique, 2092 Tunis, Tunisia
| | | | | | | | | | | | | |
Collapse
|
6
|
Ma J, Yuan ZZ, Kong XW, Wang H, Li YM, Xiao H, Zhao G. Reagent-Controlled Tandem Reactions of Vinyl Epoxides: Access to Functionalized γ-Butenolides. Org Lett 2016; 18:1450-3. [DOI: 10.1021/acs.orglett.6b00392] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Juan Ma
- Department
of Pharmaceutical Engineering, Hefei University of Technology, 193 Tunxi
Road, Hefei 230009, P. R. China
| | - Zhe-zhe Yuan
- Department
of Pharmaceutical Engineering, Hefei University of Technology, 193 Tunxi
Road, Hefei 230009, P. R. China
| | - Xiang-wen Kong
- Department
of Pharmaceutical Engineering, Hefei University of Technology, 193 Tunxi
Road, Hefei 230009, P. R. China
| | - Huai Wang
- Department
of Pharmaceutical Engineering, Hefei University of Technology, 193 Tunxi
Road, Hefei 230009, P. R. China
| | - Yi-ming Li
- Department
of Pharmaceutical Engineering, Hefei University of Technology, 193 Tunxi
Road, Hefei 230009, P. R. China
| | - Hua Xiao
- Department
of Pharmaceutical Engineering, Hefei University of Technology, 193 Tunxi
Road, Hefei 230009, P. R. China
- Key
Laboratory of Synthetic Chemistry of Natural Substances, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling
Lu, Shanghai 200032, P. R. China
| | - Gang Zhao
- Key
Laboratory of Synthetic Chemistry of Natural Substances, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling
Lu, Shanghai 200032, P. R. China
| |
Collapse
|
7
|
Mao W, Zhu C. Synthesis of highly substituted γ-hydroxybutenolides through the annulation of keto acids with alkynes and subsequent hydroxyl transposition. Chem Commun (Camb) 2016; 52:5269-72. [DOI: 10.1039/c6cc01554a] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
A BF3-catalyzed, practical synthesis of highly functionalized γ-hydroxybutenolides with a 100% atom efficiency is described.
Collapse
Affiliation(s)
- Wenbin Mao
- Key Laboratory of Organic Synthesis of Jiangsu Province
- College of Chemistry
- Chemical Engineering and Materials Science
- Soochow University
- Suzhou
| | - Chen Zhu
- Key Laboratory of Organic Synthesis of Jiangsu Province
- College of Chemistry
- Chemical Engineering and Materials Science
- Soochow University
- Suzhou
| |
Collapse
|
8
|
Vasamsetty L, Khan FA, Mehta G. A short, general, Suzuki–Miyaura coupling anchored approach to 3-alkenylbutenolides: total synthesis of akolactones A & B, hamabiwalactone B and ancepsenolide. Tetrahedron 2015. [DOI: 10.1016/j.tet.2015.04.009] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
9
|
Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, Porter CJH. Strategies to address low drug solubility in discovery and development. Pharmacol Rev 2013; 65:315-499. [PMID: 23383426 DOI: 10.1124/pr.112.005660] [Citation(s) in RCA: 1003] [Impact Index Per Article: 91.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
Drugs with low water solubility are predisposed to low and variable oral bioavailability and, therefore, to variability in clinical response. Despite significant efforts to "design in" acceptable developability properties (including aqueous solubility) during lead optimization, approximately 40% of currently marketed compounds and most current drug development candidates remain poorly water-soluble. The fact that so many drug candidates of this type are advanced into development and clinical assessment is testament to an increasingly sophisticated understanding of the approaches that can be taken to promote apparent solubility in the gastrointestinal tract and to support drug exposure after oral administration. Here we provide a detailed commentary on the major challenges to the progression of a poorly water-soluble lead or development candidate and review the approaches and strategies that can be taken to facilitate compound progression. In particular, we address the fundamental principles that underpin the use of strategies, including pH adjustment and salt-form selection, polymorphs, cocrystals, cosolvents, surfactants, cyclodextrins, particle size reduction, amorphous solid dispersions, and lipid-based formulations. In each case, the theoretical basis for utility is described along with a detailed review of recent advances in the field. The article provides an integrated and contemporary discussion of current approaches to solubility and dissolution enhancement but has been deliberately structured as a series of stand-alone sections to allow also directed access to a specific technology (e.g., solid dispersions, lipid-based formulations, or salt forms) where required.
Collapse
Affiliation(s)
- Hywel D Williams
- Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia
| | | | | | | | | | | | | |
Collapse
|
10
|
|
11
|
McConnell O, Bach A, Balibar C, Byrne N, Cai Y, Carter G, Chlenov M, Di L, Fan K, Goljer I, He Y, Herold D, Kagan M, Kerns E, Koehn F, Kraml C, Marathias V, Marquez B, McDonald L, Nogle L, Petucci C, Schlingmann G, Tawa G, Tischler M, Williamson RT, Sutherland A, Watts W, Young M, Zhang MY, Zhang Y, Zhou D, Ho D. Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery—Building chiral technology toolboxes. Chirality 2007; 19:658-82. [PMID: 17390370 DOI: 10.1002/chir.20399] [Citation(s) in RCA: 82] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
The application of Chiral Technology, or the (extensive) use of techniques or tools for the determination of absolute stereochemistry and the enantiomeric or chiral separation of racemic small molecule potential lead compounds, has been critical to successfully discovering and developing chiral drugs in the pharmaceutical industry. This has been due to the rapid increase over the past 10-15 years in potential drug candidates containing one or more asymmetric centers. Based on the experiences of one pharmaceutical company, a summary of the establishment of a Chiral Technology toolbox, including the implementation of known tools as well as the design, development, and implementation of new Chiral Technology tools, is provided.
Collapse
Affiliation(s)
- Oliver McConnell
- Wyeth Research, Chemical and Screening Sciences, Collegeville, PA 19426, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Höltke C, Law MP, Wagner S, Breyholz HJ, Kopka K, Bremer C, Levkau B, Schober O, Schäfers M. Synthesis, in vitro pharmacology and biodistribution studies of new PD 156707-derived ET(A) receptor radioligands. Bioorg Med Chem 2005; 14:1910-7. [PMID: 16289856 DOI: 10.1016/j.bmc.2005.10.039] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2005] [Accepted: 08/16/2005] [Indexed: 12/31/2022]
Abstract
It is assumed that the regulation of cardiac endothelin (ET) receptor density is abnormal in heart diseases. From that perspective, an ET receptor radioligand is needed to assess ET receptor density in vivo. The nonpeptidyl ET(A) receptor antagonist PD 169390 was labelled with radioiodine to give a putative radioligand for SPECT. Labelling with [125I]iodide and [123I]iodide was accomplished with good to excellent radiochemical yields. The affinities of the nonradioactive reference and those of selected precursor compounds for ET(A) receptors were determined, using [125I]iodine labelled endothelin-1 with mouse ventricular membranes. All employed substances exhibited potent in vitro pharmacological characteristics with Ki values comparable to that of the lead compound PD 156707. Biodistribution studies and scintigraphic imaging experiments in mice, however, showed no significant uptake of the [123I] derivative in the heart.
Collapse
Affiliation(s)
- Carsten Höltke
- Department of Nuclear Medicine, Albert-Schweitzer-Str. 33, University Hospital Münster, 48149 Münster, Germany.
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Angell P, Zhang J, Belmont D, Curran T, Davidson JG. Mucohalic acid in Lewis acid catalyzed Mukaiyama aldol reaction: a concise method for highly functionalized γ-substituted γ-butenolides. Tetrahedron Lett 2005. [DOI: 10.1016/j.tetlet.2005.01.147] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
14
|
Page NM. Therapeutic patents for the treatment of pre-eclampsia. Expert Opin Ther Pat 2005. [DOI: 10.1517/13543776.14.11.1579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
15
|
Zora M, Yucel B, Bekir Peynircioglu N. Coupling of ferrocenyl chromium carbene complex with cyclobutenediones. J Organomet Chem 2002. [DOI: 10.1016/s0022-328x(02)01403-1] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
16
|
Dasgupta F, Gangadhar N, Bruhaspathy M, Verma AK, Sarin S, Mukherjee AK. Peptoids as endothelin receptor antagonists. Bioorg Med Chem Lett 2001; 11:555-7. [PMID: 11229770 DOI: 10.1016/s0960-894x(01)00009-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
A series of new peptoids as endothelin receptor antagonists has been synthesized. Screening them for their ability to bind with endothelin receptors (ET(A) and ET(B)) competitively in the presence of (125I) endothelin led to the discovery of compounds as possible leads with IC50s in the low micromolar concentrations.
Collapse
Affiliation(s)
- F Dasgupta
- New Drug Discovery Research, Ranbaxy Laboratories Limited, New Delhi, India.
| | | | | | | | | | | |
Collapse
|
17
|
Chapter 8. Recent advances in endothelin antagonism. ANNUAL REPORTS IN MEDICINAL CHEMISTRY 2000. [DOI: 10.1016/s0065-7743(00)35009-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register]
|